We will also be hosting a kiosk in the NSF/NIH Sponsored Innovation Zone (Look for the Moose!)
The more we learn about the mechanisms of drug activity, the more we realize that these mechanisms are far more nuanced than ever imagined.
For example, some GPCR agonists signal through multiple pathways that can be detected by measuring multiple signals simultaneously in the living cell.
In other cases, the key response depends upon the presence of multiple GPCRs in a specific cell type, such as a neuron. The location and the duration of the response may be critical in other situations.
Montana Molecular’s technologies are unique because they detect these biological characteristics of a response very early in the drug discovery process.
Our goal is to provide the BIO community with better options for detecting the biological effects of drugs – in pancreatic islets, neurons, cardiomyocytes, osteoblasts or iPSC-derived lines– before taking their lead compounds to the clinic.